[1] Monteiro AR, Barbosa DJ, Remião F, et al. Alzheimer′s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs[J]. Biochem Pharmacol, 2023,211:115522. doi: 10.1016/j.bcp.2023.115522. [2] Zou D, Liu R, Lv Y, et al. Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer′s disease[J]. J Enzyme Inhib Med Chem, 2023,38:2270781. doi: 10.1080/14756366.2023.2270781. [3] Jucker M, Walker LC. Alzheimer′s disease: from immunotherapy to immunoprevention[J]. Cell, 2023,186:4260-4270. [4] Canet G, Zussy C, Hernandez C, et al. The pathomimetic oAβ25-35 model of Alzheimer′s disease: potential for screening of new therapeutic agents[J]. Pharmacol Ther, 2023,245:108398. doi: 10.1016/j.pharmthera.2023.108398. [5] Li HT, Yan JB, Li J, et al. Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice[J]. World J Gastroenterol, 2005,11:2858-2863. [6] Yuan SM, Gao K, Wang DM, et al. Evodiamine improves congnitive abilities in SAMP8 and APP(swe)/PS1(ΔE9) transgenic mouse models of Alzheimer′s disease[J]. Acta Pharmacol Sin, 2011,32:295-302. [7] McGhee JR. The world of TH1/TH2 subsets: first proof[J]. J Immunol, 2005,175:3-4. [8] Zhang Y, Chen J, Li Y, et al. Disease-modifying therapies for Alzheimer′s disease: clinical trial progress and opportunity[J]. Ageing Res Rev, 2025,103:102595. doi: 10.1016/j.arr.2024.102595. [9] 2024 Alzheimer′s disease facts and figures[J]. Alzheimers Dement, 2024,20:3708-3821. [10] Usman MB, Bhardwaj S, Roychoudhury S, et al. Immunotherapy for Alzheimer′s Disease: current scenario and future perspectives[J]. J Prev Alzheimers Dis, 2021,8:534-551. [11] Mantile F, Prisco A. Vaccination against β-amyloid as a strategy for the prevention of Alzheimer′s disease[J]. Biology (Basel), 2020,9. doi: 10.3390/biology9120425. [12] O′Nuallain B, Williams AD, McWilliams-Koeppen HP, et al. Anti-amyloidogenic activity of IgGs contained in normal plasma[J]. J Clin Immunol, 2010,30 Suppl 1:S37-S42. [13] Dodel R, Balakrishnan K, Keyvani K, et al. Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer′s disease[J]. J Neurosci, 2011,31:5847-5854. [14] Fung J, Frost D, Chakrabartty A, et al. Interaction of human and mouse abeta peptides[J]. J Neurochem, 2004,91:1398-1403. |